-
Lauren Williamson
Dr. Lauren Williamson is a translational immunologist specializing in the development of next-generation antibody therapeutics for infectious diseases, cancer, and autoimmunity. At Vanderbilt, she leads initiatives in antibody discovery and engineering, with a focus on monoclonal and bispecific…
-
Alex G. Waterson
Dr. Alex Waterson is a medicinal chemist and drug discovery leader focused on translating early-stage research into novel cancer therapies. As a project leader in the Fesik lab, Director of the Vanderbilt Center for Cancer Drug Discovery, and Associate Director for Medicinal Chemistry at the…
-
Robert Carnahan
Dr. Robert Carnahan is a translational scientist and antibody engineer specializing in rapid therapeutic development for emerging infectious diseases. As Associate Director of the Vanderbilt Vaccine Center, he has led efforts to advance antibody candidates for Zika, Marburg, Hantavirus, and SARS…
-
Chris Vanags
Dr. Chris Vanags is an applied scientist and education entrepreneur focused on transforming research into scalable, real-world impact. As Director of the Peabody Research Office at Vanderbilt, he drives strategy for over $200M in sponsored research annually and spearheads cross-sector…
-
T. S. Harvey
Dr. T. S. Harvey leverages his expertise in medical and linguistic anthropology to develop culturally responsive health technologies that tackle global disparities. His work includes co-developing a bilingual COVID-19 self-screening platform that delivered real-time data to health officials…